Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

BioMarin Pharmaceuticals Inc. (BMRN)

NASDAQ

$64.57

$+0.64

(+1.00%)

Pre-Market

BioMarin Pharmaceuticals Inc. (BMRN) Live Price Chart

Last updated: ⁦2026-09-16 10:31:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

BioMarin Pharmaceuticals Inc. (BMRN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $64.57, with a market capitalisation of $12.86B and a P/E ratio of 170.97. Over the past 52 weeks, its price has ranged from $49.26 to $70.98. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$12.86B
Open	$63.93
Day's High	$151.75
Day's Low	$3.87
Previous Close	$64.45
Volume	118.00
Average Volume	1.97M
P/E Ratio	170.97
52-Week High	$70.98
52-Week Low	$49.26
Dividend Yield	--
Earnings Date	--

BioMarin Pharmaceuticals Inc. (BMRN) Pre-Market Stock Price

BioMarin Pharmaceuticals Inc. (BMRN) is trading at $64.57 in pre-market trading as of 2026-09-16 10:21:00, up 0.19% ($0.12) from the previous close of $64.45

Pre-market trading shows how investors are pricing BMRN before the regular session opens. The current pre-market price is near the previous close, indicating positive early trading sentiment.

BioMarin Pharmaceuticals Inc. (BMRN) 7-Day Stock Price Change

Over the past seven days, BioMarin Pharmaceuticals Inc. (BMRN) moved from $66.53 to $64.57, representing a decline of 2.95% ($1.96).

The stock traded between $63.57 and $66.88 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 1.81 million shares, up versus the previous seven-day period, indicating higher trading activity.

BMRN 52-Week Price Position

Position in Range: 70.5%

52W Low$49.26

52W High$70.98

BMRN is currently trading at $64.57, placing it 70.5% of the way from its 52-week low of $49.26 to its 52-week high of $70.98. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is BioMarin Pharmaceuticals Inc. (BMRN)?

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

BioMarin Pharmaceuticals Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	3221
Exchange	NASDAQ
Company Website	https://www.biomarin.com

How to Buy BioMarin Pharmaceuticals Inc. (BMRN) Stock on MEXC

Eligible investors can buy real shares of BioMarin Pharmaceuticals Inc. (BMRN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for BMRN and Place Your Order

Open the RealStocks trading page and search for BMRN. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is BioMarin Pharmaceuticals Inc. (BMRN) stock price today?

BioMarin Pharmaceuticals Inc. (BMRN) is currently trading at $ 64.57, up 0.19% ($0.12) from the previous close of $ 64.45. Intraday prices update in real time during regular trading hours.

2.Is BMRN stock going up or down today?

As of 2026-09-16 10:21:00, BMRN is trading at $ 64.57, up 0.19% ($0.12) from its previous close of $ 64.45. The stock has traded between $ 3.87 and $ 151.75 during today’s regular session. Past price movements do not guarantee future results.

3.What is BMRN pre-market price?

As of 2026-09-16 10:21:00, BMRN is trading at $ 64.57 in pre-market trading, up 0.19% ($0.12) from the previous close of $ 64.45. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is BMRN after-hours price?

As of 2026-09-16 10:21:00, BMRN is trading at $ 63.81 in after-hours trading, down 1.00% ($0.64) from the regular-session close of $ 64.45. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is BMRN stock trading now?

BMRN trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does BMRN sit relative to its 52-week high and low?

Over the past 52 weeks, BMRN has traded between a low of $ 49.26 and a high of $ 70.98. At $ 64.57, the stock is positioned 70.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is BioMarin Pharmaceuticals Inc. in?

BioMarin Pharmaceuticals Inc. (BMRN) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is BioMarin Pharmaceuticals Inc.'s market capitalisation and where is it listed?

BioMarin Pharmaceuticals Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 12.86B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is BMRN valued in terms of P/E ratio and EPS?

BMRN trades at a P/E ratio of 170.97, based on trailing-twelve-month EPS of $ 0.38. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does BioMarin Pharmaceuticals Inc. pay a dividend?

BioMarin Pharmaceuticals Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.